{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T19:40:15Z","timestamp":1698522015978},"reference-count":0,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T00:00:00Z","timestamp":1223510400000},"content-version":"vor","delay-in-days":3661,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Autonomic Pharmacology"],"published-print":{"date-parts":[[1998,10]]},"abstract":"<jats:p> <jats:bold>1<\/jats:bold>\u2003The aim of this study was to characterize the tachykinin receptors involved in producing plasma protein extravasation and contractile responses of the guinea\u2010pig oesophageal sphincter.<\/jats:p><jats:p> <jats:bold>2<\/jats:bold>\u2003In anaesthetized guinea\u2010pigs, the selective tachykinin NK\u20101 receptor agonist [Sar<jats:sup>9<\/jats:sup>,Met(O<jats:sub>2<\/jats:sub>)<jats:sup>11<\/jats:sup>]substance P produced plasma protein extravasation (PPE) which was not affected by the treatment with the tachykinin NK\u20102 receptor antagonist MEN 10627 (1\u2003\u03bcmol\u2003kg<jats:sup>\u2212\u22121<\/jats:sup> i.v.) or the histamine H<jats:sub>1<\/jats:sub>\u2010receptor antagonist, diphenhydramine (34.5\u2003\u03bcmol\u2003kg<jats:sup>\u2212\u22121<\/jats:sup> i.v.). However, the [Sar<jats:sup>9<\/jats:sup>,Met(O<jats:sub>2<\/jats:sub>)<jats:sup>11<\/jats:sup>]substance P\u2010induced PPE was blocked by the previous administration of the peptide tachykinin NK\u20101 receptor antagonist FK 888 or by the non\u2010peptide antagonist SR 140333, yielding ED<jats:sub>50<\/jats:sub> values of 1.1\u2003\u00b1\u20030.2 and 0.01\u2003\u00b1\u20030.004\u2003\u03bcmol\u2003kg<jats:sup>\u2212\u22121<\/jats:sup> i.v., respectively.<\/jats:p><jats:p> <jats:bold>3<\/jats:bold>\u2003The tachykinin NK\u20102 or NK\u20103 receptor agonists [\u03b2\u2010Ala<jats:sup>8<\/jats:sup>]neurokinin A (4\u201310) or [MePhe<jats:sup>7<\/jats:sup>]neurokinin B, respectively, produced a weak PPE at high doses. The effect of [MePhe<jats:sup>7<\/jats:sup>]neurokinin B\u2010induced PPE was inhibited by SR 140333.<\/jats:p><jats:p> <jats:bold>4<\/jats:bold>\u2003In the guinea\u2010pig isolated oesophageal sphincter, [Sar<jats:sup>9<\/jats:sup>,Met(O<jats:sub>2<\/jats:sub>)<jats:sup>11<\/jats:sup>]substance P did not exert any contractile effect up to 10\u2003\u03bc<jats:sc>m<\/jats:sc>. The selective tachykinin NK\u20102 receptor agonist ([\u03b2\u2010Ala<jats:sup>8<\/jats:sup>]neurokinin A (4\u201310), produced concentration\u2010dependent contractions (p<jats:italic>D<\/jats:italic><jats:sub>2<\/jats:sub>\u2003=\u20037.6\u2003\u00b1\u20030.03) which were inhibited by the selective tachykinin NK\u20102 receptor antagonist, MEN 10627 (p<jats:italic>A<\/jats:italic><jats:sub>2<\/jats:sub>\u2003=\u20038.6\u2003\u00b1\u20030.1). Also, the tachykinin NK\u20103 receptor selective agonist [MePhe<jats:sup>7<\/jats:sup>]neurokinin B induced concentration\u2010dependent contractile responses, but these responses were inhibited by MEN 10627.<\/jats:p><jats:p> <jats:bold>5<\/jats:bold>\u2003Altogether, these data indicate that the stimulation of tachykinin NK\u20101 receptor produces a vascular inflammatory response, while activation of tachykinin NK\u20102 receptors mediate the contraction of the guinea\u2010pig oesophageal sphincter.<\/jats:p>","DOI":"10.1046\/j.1365-2680.1998.185100.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T04:00:57Z","timestamp":1047441657000},"page":"313-318","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory and motor responses by tachykinins in the guinea\u2010pig oesophageal sphincter"],"prefix":"10.1111","volume":"18","author":[{"given":"B.","family":"Conte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Parlani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Manzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,9]]},"container-title":["Journal of Autonomic Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2680.1998.185100.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2680.1998.185100.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T19:17:04Z","timestamp":1698520624000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2680.1998.185100.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["10.1046\/j.1365-2680.1998.185100.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2680.1998.185100.x","archive":["Portico"],"relation":{},"ISSN":["0144-1795","1365-2680"],"issn-type":[{"value":"0144-1795","type":"print"},{"value":"1365-2680","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}